Telix Pharmaceuticals Financials
| TLX Stock | 15.76 0.16 1.03% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 1.4284 |
|
|
The essential information of the day-to-day investment outlook for Telix Pharmaceuticals includes many different criteria found on its balance sheet. An individual investor should monitor Telix Pharmaceuticals' cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Telix Pharmaceuticals.
Net Income |
|
Telix | Select Account or Indicator |
Please note, the imprecision that can be found in Telix Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Telix Pharmaceuticals Limited. Check Telix Pharmaceuticals' Beneish M Score to see the likelihood of Telix Pharmaceuticals' management manipulating its earnings.
Telix Pharmaceuticals Stock Summary
Telix Pharmaceuticals competes with HUTCHMED DRC, Vestis, Xponential Fitness, HE Equipment, and Air Lease. Telix Pharmaceuticals is entity of United States. It is traded as Stock on NASDAQ exchange.| Foreign Associate | Australia |
Specialization | Healthcare, Biotechnology |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| Location | Australia |
| Business Address | 55 Flemington Road, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | telixpharma.com |
| Phone | 61 3 9093 3855 |
Telix Pharmaceuticals Key Financial Ratios
| Return On Equity | 0.2 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.09 % | ||||
| Price To Sales | 8.17 X | ||||
| Revenue | 496.66 M |
Telix Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Telix Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Telix Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Telix Pharmaceuticals competition to find correlations between indicators driving Telix Pharmaceuticals's intrinsic value. More Info.Telix Pharmaceuticals Limited is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about 0.39 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Telix Pharmaceuticals Limited is roughly 2.57 . At this time, Telix Pharmaceuticals' Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Telix Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Telix Pharmaceuticals Systematic Risk
Telix Pharmaceuticals' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Telix Pharmaceuticals volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of thirteen. The Beta measures systematic risk based on how returns on Telix Pharmaceuticals correlated with the market. If Beta is less than 0 Telix Pharmaceuticals generally moves in the opposite direction as compared to the market. If Telix Pharmaceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Telix Pharmaceuticals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Telix Pharmaceuticals is generally in the same direction as the market. If Beta > 1 Telix Pharmaceuticals moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Telix Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Telix Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Telix Pharmaceuticals growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Telix Pharmaceuticals December 15, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Telix Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Telix Pharmaceuticals Limited. We use our internally-developed statistical techniques to arrive at the intrinsic value of Telix Pharmaceuticals Limited based on widely used predictive technical indicators. In general, we focus on analyzing Telix Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Telix Pharmaceuticals's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.95 | |||
| Information Ratio | 0.0443 | |||
| Maximum Drawdown | 10.19 | |||
| Value At Risk | (2.14) | |||
| Potential Upside | 4.38 |
Additional Tools for Telix Stock Analysis
When running Telix Pharmaceuticals' price analysis, check to measure Telix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telix Pharmaceuticals is operating at the current time. Most of Telix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Telix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Telix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.